Research Article
Hepatic Chemerin and Chemokine-Like Receptor 1 Expression in Patients with Chronic Hepatitis C
Table 1
General characteristics of CHC patients and controls.
| | Men = 29 (46%) | Women = 34 (54%) | | CHC patients = 63 | Control group = 30 | |
| Age (years) | 48.2 ± 16.6 | 45.3 ± 12.8 | NS | 46.6 ± 14.6 | 47.9 ± 14.8 | NS | Body mass index (kg/m2) | 25.7 ± 2.6 | 24.0 ± 3.1 | 0.02 | 24.8 ± 3.0 | 23.9 ± 3.3 | NS | Waist circumference (cm) | 87.8 ± 11.2 | 79.4 ± 12.5 | 0.03 | 87.8 ± 11.2 | 85.5 ± 8.7 | NS | Systolic blood pressure (mmHg) | 135.0 ± 18.8 | 125.0 ± 12.5 | 0.02 | 129.0 ± 14.4 | 115.0 ± 10.5 | NS | Diastolic blood pressure (mmHg) | 79.1 ± 8.9 | 80.0 ± 9.5 | NS | 79.6 ± 9.0 | 77.1 ± 6.6 | NS | Insulin (U/L) | 10.6 ± 6.3 | 12.4 ± 11.8 | NS | 11.6 ± 9.6 | 10.0 ± 4.5 | NS | Glucose (mg/dL) | 95.1 ± 16.4 | 92.6 ± 15.8 | NS | 93.7 ± 16.0 | 80.8 ± 9.0 | NS | HOMA-IR | 2.5 ± 1.3 | 3.4 ± 3.5 | NS | 2.9 ± 2.7 | 2.0 ± 0.5 | 0.03 | Bilirubin (mol/L) | 15.1 ± 4.1 | 13.6 ± 11.2 | NS | 14.3 ± 8.7 | 9.7 ± 3.5 | 0.02 | GGT (U/L) | 104.8 ± 119.2 | 60.2 ± 34.5 | 0.04 | 80.7 ± 86.9 | 26.0 ± 5.5 | 0.04 | ALT (U/L) | 83.2 ± 50.8 | 98.8 ± 37.7 | NS | 75.4 ± 44.5 | 25.6 ± 4.3 | 0.001 | AST (U/L) | 54.2 ± 28.5 | 59.5 ± 22.5 | NS | 51.7 ± 25.3 | 24.1 ± 3.8 | 0.004 | Total cholesterol (mg/dL) | 200.9 ± 44.3 | 178.2 ± 54.6 | NS | 188.3 ± 50.9 | 174.6 ± 33.2 | NS | LDL cholesterol (mg/dL) | 84.2 ± 38.9 | 108.6 ± 51.5 | NS | 97.2 ± 47.2 | 94.5 ± 20.2 | NS | HDL cholesterol (mg/dL) | 51.2 ± 28.2 | 53.4 ± 21.3 | NS | 52.4 ± 24.2 | 44.0 ± 12.8 | NS | Triglycerides (mg/dL) | 134.8 ± 57.4 | 128.3 ± 63.00 | NS | 131.0 ± 60.1 | 139.0 ± 45.0 | NS | CRP (mg/dL) | 1.8 ± 1.1 | 1.6 ± 1.4 | NS | 1.7 ± 1.2 | 1.5 ± 1.4 | NS | HCV viral load (IU/L) | 2781433 ± 487426 | 1432246 ± 1976597 | NS | 2053301 ± 364614 | | |
|
|
: men versus women; ∗∗: CHC patients versus controls.
|